Thyroid Hormones and the Metabolic Syndrome.

European thyroid journal 06/2013; 2(2):83-92. DOI: 10.1159/000351249
Source: PubMed

ABSTRACT Clustering of various metabolic parameters including abdominal obesity, hyperglycaemia, low high-density lipoprotein cholesterol, elevated triglycerides and hypertension have been used worldwide as metabolic syndrome to predict cardiometabolic risk. Thyroid dysfunction impacts on various levels of these components.
The purpose of the present review is to summarize available data on thyroid hormone-dependent action on components of the metabolic syndrome.
A PubMed search for any combination of hyperthyroidism, thyrotoxicosis or hypothyroidism and metabolic syndrome, blood pressure, hypertension, hyperlipidaemia, cholesterol, high-density lipoprotein cholesterol, glucose, diabetes mellitus, body weight or visceral fat was performed. We included papers and reviews published between 2000 and today but accepted also frequently cited papers before 2000.
There is convincing evidence for a major impact of thyroid function on all components of the metabolic syndrome, reflecting profound alterations of energy homeostasis at many levels.
Even though the interactions shown in animal models and man are complex, it is evident that insulin sensitivity is highest and adverse thyroid effects on the metabolic system are lowest in euthyroid conditions.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The effect of triiodothyronine treatment on fatty acid synthesis was investigated in liver and adipose tissue of fed and 48-h fasted rats. In the liver, the thyrotoxic state was accompanied by an increased incorporation of [1-14C]acetyl-CoA to fatty acids and a rise in the activity of acetyl-CoA carboxylase and fatty acid synthetase, both in the fed and fasted rats. The activity of glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase, NADP-malate dehydro-genase and ATP citrate lyase was also enhanced by triiodothyronine treatment. Liver malate and citrate content was not changed in fed thyrotoxic rats, but was increased in fasted triiodo-thyronine-treated animals. Palmitate oxidation was increased in the liver of the same animals, either fed or fasted.The rise in acetyl-CoA carboxylase activity due to triiodothyronine administration was apparent when assayed both before and after citrate activation in vitro. Maximal activity of this enzyme in the presence of citrate was reached earlier in the liver of triiodothyronine-treated rats.In adipose tissue, triiodothyronine treatment induced an increase in the activity of acetyl-CoA carboxylase, fatty acid synthetase and in glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase. The activity of NADP-malate dehydrogenase and ATP citrate lyase was slightly but insignificantly increased. Malate and citrate levels in adipose tissue were unchanged by triiodothyronine treatment.It is suggested that the triiodothyronine-induced simultaneous stimulation of opposing pathways (the synthesis of fatty acids and their oxidation) creates a futile metabolic cycle which contributes to the general energy waste and thermogenesis characteristic of thyrotoxicosis.
    European Journal of Biochemistry 05/1972; 26(4):553-9. · 3.58 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In skeletal muscle, the main site of insulin-mediated glucose disposal, the major muscle glucose transporter GLUT4 is induced by thyroid hormone. To test the hypothesis that thyroid hormone alters muscle glucose transport, we examined the effect of L-triiodothyronine (T3) on glucose transport and GLUT4 protein content in isolated rat skeletal muscles. Euthyroid rats were treated with or without T3 for 3 days, and [3H]2-deoxy-D-glucose (2-DG) uptake in soleus and extensor digitorum longus (EDL) muscles was measured under conditions in which transport was rate limiting for uptake in the absence or presence of 10 nmol/l insulin. In control animals, insulin stimulated 2-DG uptake sevenfold in soleus and fivefold in EDL. T3 treatment increased basal 2-DG uptake in soleus and EDL by 115 +/- 29% and 136 +/- 23%, respectively, and increased insulin-stimulated 2-DG uptake in soleus and EDL by 55 +/- 9 and 42 +/- 12%, respectively. Immunoblot analysis revealed that T3 treatment increased GLUT4 protein content in soleus by 43 +/- 6% and in EDL by 56 +/- 13%. These data demonstrate that thyroid hormone increases basal and insulin-stimulated glucose transport in skeletal muscle. The percentage increase in insulin-stimulated transport in T3-treated muscles is similar to the increase in GLUT4 protein content, whereas the percentage change in basal transport greatly exceeds the change in GLUT4. Thus, increased insulin-stimulated glucose transport in T3-treated muscle can be accounted for by the induction of GLUT4 protein.(ABSTRACT TRUNCATED AT 250 WORDS)
    Diabetes 11/1994; 43(10):1185-9. · 8.47 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The extent to which the glucose transport system in hepatocytes is regulated in states of altered hepatic glucose metabolism is unclear. Because thyroid hormone is known to increase hepatic glucose output, we hypothesized that thyroid hormone might up-regulate expression of the principal hepatic glucose transporter, GLUT2, facilitating increased glucose efflux across the hepatocyte plasma membrane. GLUT2 protein concentration in crude liver membranes was twice as high in chronically hyperthyroid vs. hypothyroid animals, with intermediate levels in euthyroid controls. Similar results were obtained for total GLUT2 protein, measured in detergent extracts of liver. Northern analysis of total liver RNA demonstrated parallel changes in GLUT2 messenger RNA (mRNA) concentration per g tissue (hypothyroid, 76 +/- 6%; euthyroid, 100 +/- 11%; hyperthyroid, 158 +/- 12%; data expressed as percentage of mean euthyroid values). The daily administration of a large dose of T3 (100 micrograms/100 g BW) to hypothyroid rats caused a prompt increase in hepatic GLUT2 mRNA concentration (2.5-fold at 1 day), but only a modest and gradual change in hepatic GLUT2 protein concentration (+40% at 4 days), suggesting that the GLUT2 protein in liver may have a long half-life. We conclude that thyroid hormone regulates hepatic GLUT2 mRNA and protein expression. Up-regulation of GLUT2 protein expression by thyroid hormone may serve to facilitate increased hepatic glucose output. These results suggest that the hepatic GLUT2 glucose transporter, like the enzymes of gluconeogenesis and glycolysis, is indeed a regulatory target for hormones that control hepatic glucose metabolism.
    Endocrinology 09/1994; 135(2):649-54. · 4.64 Impact Factor

Preview (2 Sources)

Available from